LEADER 03019nam 2200685z- 450 001 9910557108203321 005 20231214133007.0 035 $a(CKB)5400000000040965 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69307 035 $a(EXLCZ)995400000000040965 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiobanking and Regenerative Medicine 210 1$aBasel, Switzerland :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2020. 215 $a1 electronic resource (100 pages) 311 $a3-03943-540-X 330 $aRegenerative medicine and tissue engineering play significant roles in the treatment of currently intractable conditions, such as chronic heart failure, stroke, chronic osteoarthritis, and other maladies. Regenerative medicine and tissue engineering generally depend on the utilization of stem cells to treat patients but may also utilize mature cells that would not normally be considered as stem cells (e.g., skin). Stem cells (like mature cells) may be obtained from many sources in the body including bone marrow, cord blood, cord tissue, adipose tissue, etc. Although stem cells are often used in therapy immediately upon isolation, in many circumstances, the stem and progenitor cells will be harvested, processed and banked frozen until a later time. Biobanking is a convenient alternative to same-day therapeutic use, in that it allows for patient recovery (e.g., from liposuction), provides time to identify the best treatment options, and may allow for multiple interventions with additional patient inconvenience or risk. 606 $aMedicine 610 $aMSCs 610 $aEVs 610 $aexosomes 610 $atissue regeneration 610 $aimmunomodulation 610 $abiobanking 610 $aadult stem cells 610 $aground-state 610 $aautologous transplantation 610 $aregenerative medicine 610 $astem cell banking 610 $anewborn stem cells 610 $aperinatal stem cells 610 $aumbilical cord tissue 610 $aumbilical cord blood 610 $aplacenta 610 $aVascular tissue engineering 610 $ahuman cord blood-derived endothelial cells 610 $aendothelialization 610 $avascular graft 610 $aMunich Vascular Biobank 610 $aatherosclerosis 610 $ahuman vascular tissue 610 $aRIN 610 $aRNA fragmentation 610 $aadipose tissue 610 $acryopreservation 610 $aautologous 610 $afat grafting 610 $acryogenic storage 610 $alipoaspirate 610 $acosmetic surgery 615 0$aMedicine. 702 $aHarris$b David A$g(David Anselm), 906 $aBOOK 912 $a9910557108203321 996 $aBiobanking and Regenerative Medicine$93423132 997 $aUNINA